about
Bacterial ratchet motors.Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates.A distinctive 'microbial signature' in celiac pediatric patientsAdherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features.Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.Higher prevalence and abundance of Bdellovibrio bacteriovorus in the human gut of healthy subjects.Dysbiotic events in gut microbiota: impact on human healthInfluenza A virus infection of intestinal epithelial cells enhances the adhesion ability of Crohn's disease associated Escherichia coli strainsMicroevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel diseaseCloning and characterization of the NapA acid phosphatase/phosphotransferase of Morganella morganii: identification of a new family of bacterial acid-phosphatase-encoding genes.Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains.Bacterial nonspecific acid phosphohydrolases: physiology, evolution and use as tools in microbial biotechnology.Double sugar-tyrosine medium improves O-1 phage Salmonella screening.The Shigella flexneri OspB effector: an early immunomodulator.Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.The molecular class C acid phosphatase of Chryseobacterium meningosepticum (OlpA) is a broad-spectrum nucleotidase with preferential activity on 5'-nucleotides.A potential role of Escherichia coli pathobionts in the pathogenesis of pediatric inflammatory bowel disease.A New Approach to Use of Bacteriolytic Enzymes as a Tool for Species Identification: Selection of Species-Specific Indicator Strains with Bacteriolytic Activity towards Enterococcus StrainsEffect of lactoferricin on fluoroquinolone susceptibility of uropathogenic Escherichia coli.Use of glucose starvation to limit growth and induce protein production in Escherichia coli.Plasmid-mediated fluoroquinolone resistance determinants in Escherichia coli from community uncomplicated urinary tract infection in an area of high prevalence of quinolone resistance.Ala160 and His116 residues are involved in activity and specificity of apyrase, an ATP-hydrolysing enzyme produced by enteroinvasive Escherichia coli.Biochemical characterization of the class B acid phosphatase (AphA) of Escherichia coli MG1655.Achromobacter xylosoxidans Genomic Characterization and Correlation of Randomly Amplified Polymorphic DNA Profiles with Relevant Clinical Features of Cystic Fibrosis Patients.Characterization and sequence of PhoC, the principal phosphate-irrepressible acid phosphatase of Morganella morganii.Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease.Rhinoviruses promote internalisation of Staphylococcus aureus into non-fully permissive cultured pneumocytesPlasmid "curing" by some recently synthetized 4-quinolone compoundsInhibition of plasmid conjugation by some recently synthetized 4-quinolone compoundsListeria monocytogenes in a young patient with non Hodgkins lymphoma: case reportViolacein and biofilm production in Janthinobacterium lividumVirulence traits in Escherichia coli strains isolated from outpatients with urinary tract infectionsGut microbiota and the immune system: an intimate partnership in health and disease
P50
Q30495578-935C921A-FE45-44CA-9D49-1C6390C1B592Q30579959-4C5DABC7-4C10-4BDA-9B3B-89B1B26C1AC5Q33610793-E3A05AF4-A9E9-4E19-8E10-EB42060838F8Q34410373-0940C798-2EAD-4D3C-A926-D4835D508B48Q34647371-3AB9D773-A68F-4D9F-88AC-2C7400FBFC23Q34684122-C21BC20F-76EA-4C06-B2D4-5471F3B720FEQ34684626-3A3A4B51-62CD-4B0D-8FFF-586ACD44FF76Q34775051-67F73019-E9A1-4A43-A5CE-F4D9E24A9860Q35565733-D8B5BB94-C775-41B1-AD3F-762ECDDD2B97Q35867599-49580E79-60B8-42D0-B577-C42E7AB39C53Q36720272-AFF22AC5-A19C-44EF-A7EA-E02ED1083D07Q37695294-60C922DA-D286-4CC3-8D42-8BDC466712BAQ38549832-0063C118-35D3-45B7-B17C-53EB99D7C582Q40185433-8C7B7FFE-3808-4E28-88D0-D900606936FEQ41642747-7C7B8D54-B306-491E-918E-D5E427BD5FB3Q42151699-161161FB-AA54-46DA-9349-0C03C27E1BCEQ44448441-3B30B1CF-4A46-4B3F-A538-90B21B0DDD1EQ44693025-483181F6-6603-4EDB-9084-C09801DA437AQ45312122-1CC1C852-65E3-4D24-93FD-3992F43A2806Q46130879-196D5A19-92FC-47D6-AE1F-39AA52E7F875Q46161014-825565D8-A1E6-4438-8218-58FDBB66251EQ46417655-CCAADD6A-7F22-450B-8146-4D9FB4A7BAD7Q46693690-B517FC8C-2F37-463D-AD55-FE7F899620C4Q46811637-FFDDAB38-D375-4B2C-9B6E-5B4D9D3C6BDEQ46880058-91EC357B-A14D-4EB8-927E-8CA52170D70DQ48082012-DDE85634-C60C-49A3-8B53-6F9EAAAA51B0Q54412645-93B934D3-8E9A-477A-9CAA-6AE8FA7F0E1AQ58960780-E2231B90-8369-4C6E-A168-A9A92AD6579CQ70246958-7C933F83-C1AB-4588-A054-444D292C2EF4Q70246963-43BD8955-134B-43BC-A9D2-AB3AA38A3D7FQ79430836-D2C09B80-BFEA-446C-9089-A26110CDA35AQ80025782-636B0D42-3FCC-4BB4-8084-A1366F4D35D6Q82189664-99975224-FCDA-451D-B8E4-6A83DAB91349Q85854524-13BAD53E-8496-47CC-9C0F-3592A830A7D6
P50
description
researcher ORCID ID = 0000-0003-1572-2623
@en
wetenschapper
@nl
name
Serena Schippa
@ast
Serena Schippa
@en
Serena Schippa
@es
Serena Schippa
@nl
type
label
Serena Schippa
@ast
Serena Schippa
@en
Serena Schippa
@es
Serena Schippa
@nl
prefLabel
Serena Schippa
@ast
Serena Schippa
@en
Serena Schippa
@es
Serena Schippa
@nl
P106
P31
P496
0000-0003-1572-2623